| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/17/2003 | US20030134380 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134379 Nucleic acid molecule comprising a nucleotide sequence that encodes a PRO polypeptide |
| 07/17/2003 | US20030134378 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134377 Nucleic acid molecule comprising a nucleotide sequence that encodes a PRO polypeptide |
| 07/17/2003 | US20030134376 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134375 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134374 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134373 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134372 Nucleic acid molecule comprising a nucleotide sequence that encodes a PRO polypeptide |
| 07/17/2003 | US20030134371 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134370 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134369 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134368 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134367 Vectors with DNA encoding pro polypeptides |
| 07/17/2003 | US20030134366 Vectors with DNA encoding pro polypeptides |
| 07/17/2003 | US20030134365 Vectors with DNA encoding pro polypeptides |
| 07/17/2003 | US20030134364 Vectors with DNA encoding pro polypeptides |
| 07/17/2003 | US20030134363 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134362 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134361 Vectors with DNA encoding pro polypeptides |
| 07/17/2003 | US20030134360 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134359 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134358 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134357 Vectors with DNA encoding pro polypeptides |
| 07/17/2003 | US20030134356 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134355 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134354 Vectors with DNA encoding pro polypeptides |
| 07/17/2003 | US20030134350 Zinc finger domain recognition code and uses thereof |
| 07/17/2003 | US20030134346 Binding protein as biosensors |
| 07/17/2003 | US20030134345 Isolating an immune complex, incubating to dissociate, reassociating, separating from the solution, using a binding agent on a solid phase |
| 07/17/2003 | US20030134343 Contacting a sample with an antibody or fragment having binding affinity for mucin, so a complex forms and isolating the complex; early diagnosis |
| 07/17/2003 | US20030134342 Binding-specific peptides, binding-specific carrier molecules, and uses thereof |
| 07/17/2003 | US20030134340 Method for detecting pathogenic prion proteins by means of mass spectroscopy |
| 07/17/2003 | US20030134339 Proteomics based method for toxicology testing |
| 07/17/2003 | US20030134337 Muscle sample prepared for prion assay |
| 07/17/2003 | US20030134336 Change in the expression density, of a cell adhesion molecule is determined |
| 07/17/2003 | US20030134334 Use of vascular endothelial growth factor (VEGF) |
| 07/17/2003 | US20030134333 Tagged microparticle compositions and methods |
| 07/17/2003 | US20030134332 Diagnosis of endothelial dysfunction by nitric oxide bioactivity index |
| 07/17/2003 | US20030134331 Controlling pathways that regulate muscle contraction in the heart |
| 07/17/2003 | US20030134330 Multiplexed detection and quantification of analytes by reacting them with probe molecules attached to specific and identifiable supports |
| 07/17/2003 | US20030134326 Methods for determining polypeptide structure, function or pharmacophore from comparison of polypeptide sequences |
| 07/17/2003 | US20030134325 Modified phycobilisomes and uses therefore |
| 07/17/2003 | US20030134323 Methods of identifying agents that affect cleavage of amyloid-beta precursor protein |
| 07/17/2003 | US20030134322 Solid phase thermoplastic or thermosetting resin substrate having a DNA or RNA embedded therein for hybridization assays and immunoassays to detect antinucleic acid antibody |
| 07/17/2003 | US20030134321 High resolution DNA detection methods and devices |
| 07/17/2003 | US20030134319 Amino acid sequences of peptides that are encoded by genes within the human genome, the kinase peptides |
| 07/17/2003 | US20030134318 Methods of using randomized libraries of zinc finger proteins for the identification of gene function |
| 07/17/2003 | US20030134316 Method of stirring reaction solutions |
| 07/17/2003 | US20030134315 Testing a sample from a cancer patient for the expression of a negative signal transduction factor (NSTF) and for the expression of a positive signal transduction factor (PSTF), selecting chemotherapeutic agent for treatment based on above |
| 07/17/2003 | US20030134314 Assaying the ability of specific polypeptide activity, thereby identifying a compound capable of treating a hematologic disorder |
| 07/17/2003 | US20030134309 Detection of hypermutable nucleic acid sequence in tissue |
| 07/17/2003 | US20030134308 Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma |
| 07/17/2003 | US20030134306 Human and murine cytokine polypeptides |
| 07/17/2003 | US20030134305 Toxicology; assessing DNA damaging potential of drugs undergoing clinical trials; evaluating patient-specific responses to chemotherapy or radiation therapy; evaluating compounds, diets, or other factors that may damage DNA |
| 07/17/2003 | US20030134304 Spectrometric measurements of the samples of bio-fluid, evaluating multi data sets with multivariate analysis, determiing correaltion between one of the one or more sets of differences, developing profile of a biological system |
| 07/17/2003 | US20030134303 Adenine nucleotide-binding protein-directed probes, and methods of their synthesis and use |
| 07/17/2003 | US20030134301 Nucleic acids, their expression products and pathways involved in pain, and their use in screening for molecule that can alleviate pain |
| 07/17/2003 | US20030134299 Surface saturation surfaces; hybrid nucleic acid |
| 07/17/2003 | US20030134297 Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection |
| 07/17/2003 | US20030134294 Radiation transparent polyurethane gel |
| 07/17/2003 | US20030134288 Screening methods involving the detection of short-lived proteins |
| 07/17/2003 | US20030134287 Fusion protein; cell libraries; gene expression |
| 07/17/2003 | US20030134286 Multilayer support of polylactone or polyamide and cationic polymer |
| 07/17/2003 | US20030134284 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134282 Quantitative analysis of tissue gene expression; amplification; polymerase chain reaction |
| 07/17/2003 | US20030134278 Chromosome inheritance modifiers and their uses |
| 07/17/2003 | US20030134270 Rapid method of selecting cells for gene disruption by homologous recombination |
| 07/17/2003 | US20030134269 Anchoring cells; culture product; imaging, detection |
| 07/17/2003 | US20030134267 Sensor for detecting biomolecule using carbon nanotubes |
| 07/17/2003 | US20030134266 Methods of screening for compounds that modulate blood vessel formation |
| 07/17/2003 | US20030134265 Screening method for nucleic acids |
| 07/17/2003 | US20030134263 Controlling gene expression; transfection of cell |
| 07/17/2003 | US20030134042 Method of treating a surface of an object with a hydrophobin-containing solution |
| 07/17/2003 | US20030134033 Combinatorial screening/testing apparatus and method |
| 07/17/2003 | US20030133949 Providing bacteria which are modified to produce first signal, exposure the the material being evaluated to the bacteria on fisrst side to determine whether the first signal is present on second side or within the material |
| 07/17/2003 | US20030133948 An expression vector, comprising a) coding sequences for i) the viral nucleic acid-binding protein LANA ii) a therapeutic gene, and b) viral nucleic acid to which above viral nucleic acid-binding protein will bind |
| 07/17/2003 | US20030133936 Modulating glucocorticoid induced tumor necrosis factor receptor (GITR) with an agent (antibody, a small molecular agonist antagonist antibodies) that binds GITR to potentiate regulatory T cell function |
| 07/17/2003 | US20030133933 Novel integrin alpha subunit |
| 07/17/2003 | US20030133931 Combining a putative modulator compound of mammalian histamine H4 receptor protein activity with mammalian histamine H4 receptor protein and a known histamine receptor H4 ligand, measuring the effect of the modulator on the protein |
| 07/17/2003 | US20030133913 Producing chemokine receptors, inducing antigen by dendritic cells in vitro, for therapeutic or prophylactic purposes |
| 07/17/2003 | US20030133910 Inhibiting cell proliferation by administering a large dosage of wild-type ras proteins |
| 07/17/2003 | US20030133875 Assay for screening candidate drug for the treatment of inflammatory diseases and methods for treating the same |
| 07/17/2003 | US20030133874 Analytical method to evaluate animal models of neurofibrillary degeneration |
| 07/17/2003 | US20030133873 Determining minimum optimum aspirin dose for inhibiting platelet activation in patient treatment by measuring base level of thromboxane B2 metabolite in test sample, determining level of platelet activation, identifying aspirin dosage |
| 07/17/2003 | US20030133871 Administering labeled water to individual over time for label to be incorporated into proteins or peptides, obtaining body tissues or fluids from individual, detecting incorporation of label in proteins or peptides to determine biosynthetic rate |
| 07/17/2003 | US20030133847 Air and moisture tight sealed |
| 07/17/2003 | US20030133846 Processing chamber |
| 07/17/2003 | US20030133845 Identification device for explosives or other materials |
| 07/17/2003 | US20030133840 Segmented area detector for biodrive and methods relating thereto |
| 07/17/2003 | US20030133838 Precise test elements in which the test spots have different compositions |
| 07/17/2003 | US20030133119 Rapid imaging of particles in a large fluid volume through flow cell imaging |
| 07/17/2003 | US20030132740 Method and apparatus for the debris particulate characterizaion in lubricants |
| 07/17/2003 | US20030132538 Encapsulation of discrete quanta of fluorescent particles |
| 07/17/2003 | US20030132406 Sensor element for optically detecting chemical or biochemical analytes |
| 07/17/2003 | US20030132162 Underdrain for filtration membrane |
| 07/17/2003 | US20030132125 Following addition of known amount of transition metal ion to patient sample, electrodes are used to measure current or potential difference of non-sequestered transition metal ion in sample |
| 07/17/2003 | US20030132117 Thin film electrophoresis apparatus and method |
| 07/17/2003 | US20030132114 Method and device for the qualitative and / or quantitative analysis of a protein and/or peptide pattern of a liquid samle that is derived from the human or animal body |
| 07/17/2003 | US20030132110 Whole blood is measured, wherein plasma of blood, with hemocytes thereof having been filtered out, is allowed to quickly reach an electrode system; high speed, accuracy |